Previous Article | Next Article ![]()
Infection and Immunity, October 2002, p. 5412-5415, Vol. 70, No. 10
0019-9567/02/$04.00+0 DOI: 10.1128/IAI.70.10.5412-5415.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Department of Medicine, University of Melbourne, Royal Melbourne Hospital, Victoria 3050, Australia,1 Malawi-Liverpool-Wellcome Trust Clinical Research Programme, College of Medicine, University of Malawi, Blantyre, Malawi2
Received 20 May 2002/ Returned for modification 29 June 2002/ Accepted 18 July 2002
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
Studies in Africa have implicated parasite adhesion to chondroitin sulfate A (CSA) and hyaluronic acid (HA), present on syncytiotrophoblasts, in parasite sequestration in the placenta (reviewed in reference 3). IEs isolated from infected placentas typically adhere to CSA and HA in vitro rather than to other known host adhesion molecules (2, 4, 9). Recently, parasite binding to immunoglobulins has been suggested as an additional mechanism involved in placental infection (8).
Cell adhesion is predominantly a feature of mature-stage IEs, pigmented trophozoites, and schizonts and is mediated by the expression of parasite-derived proteins on the surface of the erythrocyte (11). Of these, the variant protein P. falciparum erythrocyte membrane protein 1 (PfEMP1) mediates adhesion to CSA (16) and other receptors (1) and is expressed on the IE surface of late-ring-stage and mature pigmented IEs, from approximately 16 to 48 h of the 48-h life cycle (10, 23). The expression of PfEMP1 corresponds with the disappearance from the peripheral circulation of mature IEs, which are thought to sequester in deep vascular beds to avoid splenic clearance (17).
The hypothesis that parasites sequester in the placenta due to cell adhesive processes, largely mediated by PfEMP1, implies that only mature stages of IEs would specifically accumulate. However, to our knowledge this has not been formally assessed. Although some studies have reported a predominance of mature IEs in the placenta (6), it has also been proposed that parasites might replicate locally within the placenta (22), and recent studies have suggested that early developmental stages, or ring forms, can adhere and sequester in the placenta and brain (14, 20).
To address these issues in placental malaria, we have assessed and compared the parasitemias and developmental stages of IEs present in the placenta and peripheral blood of matched samples from the same individuals.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Immediately following delivery, several biopsies of placental tissue (approximately 1.5 to 2 cm in each dimension, up to 6 cm3) were cut from different areas of the maternal side of the placenta that appeared grossly normal. For preparation of placental histology sections, biopsy tissue was fixed in neutral buffered formalin and paraffin embedded. Sections were made and stained with Giemsa using standard methods. Placental blood containing parasites was washed from placental tissue by incubating several biopsy samples together in a 50-ml tube containing phosphate-buffered saline (pH 7.2) with 50 mM EDTA (the placental tissue occupied no more than one-third of the volume) on a tube roller for 60 min at room temperature. This method was previously found to be an effective way of isolating viable parasites from infected placentas (2). After removal of placental tissue and supernatant, cells harvested were examined by microscopy of thin smears fixed with methanol and stained with Giemsa or Field's stain. At least 600 infected and uninfected erythrocytes were counted to calculate the parasitemia, and at least 500 parasitized red blood cells were examined to determine the proportion of developmental stages present. Parasite stages were also assessed by histological examination. Assessments of peripheral blood parasitemia, which was typically low to very low, and parasite stages were performed on Field's-stained thick blood films, collected at the same time as placental samples. Parasitemia was determined by counting the number of IEs relative to the number of leukocytes. In this population of infected pregnant women at term, the mean ± standard deviation leukocyte count was (10.9 ± 4.3) x 109/liter, and the mean erythrocyte count was (4.2 ± 0.7) x 1012/liter (S. J. Rogerson, unpublished observations). A minimum of 200 IEs were examined to determine the proportion of each developmental stage present.
Parasitized red blood cells were classified into three developmental stages (20, 21): ring forms (no malaria pigment visible, width of cytoplasm up to twice the width of the nucleus, approximately 0 to 24 h postinvasion); pigmented trophozoites (pigment visible, single nucleus, approximately 24 to 36 h postinvasion); or schizonts (pigment visible, multiple nuclei, approximately 36 to 48 h postinvasion).
Ethical approval for all aspects of the study was obtained from the College of Medicine Research Committee, University of Malawi, Blantyre, Malawi.
| RESULTS AND DISCUSSION |
|---|
|
|
|---|
|
|
These findings indicate that IEs selectively accumulate in the blood spaces of the placenta. This is predominantly a feature of pigmented trophozoites, which express PfEMP1 on their surface (11) and may adhere to CSA and HA or bind immunoglobulins (4, 8, 14, 18). The intraerythrocytic parasite life cycle lasts approximately 48 h, with 24 h in the ring stage, 12 h as pigmented trophozoites, and 12 h as schizonts (20). Therefore, in the absence of selective processes, random sampling of parasites should yield approximately 50% ring-stage IEs, 25% pigmented trophozoites, and 25% schizonts. However, in the placenta around 90% of all IEs examined were mature forms. In contrast to the accumulation of mature asexual-stage parasites, the sexual forms of P. falciparum, gametocytes, do not appear to sequester in the placenta (7).
To assess the possibility that ring-stage parasites specifically accumulate in the placenta (14), we calculated ring-stage parasitemia based on the parasitemia and proportion of ring forms present in smears of placental washings and peripheral blood for 14 matched cases (Table 1). The average ring-stage parasitemia among placental samples was not significantly different (P = 0.535; Wilcoxon's test) from that of matched peripheral blood samples (mean ± SEM, 0.73% ± 0.19%, and median, 0.58% for placental samples; for peripheral blood samples, mean ± SEM, 1.23% ± 0.47%, and median, 0.58%).
Overall, these findings do not support a major role for the sequestration of ring-stage IEs or local parasite replication in the placenta. A high proportion (36 to 41%) of ring forms in three placentas (Table 1, cases F, J, and K) and a substantially higher ring parasitemia in placental than peripheral blood of one case (Table 1, case B) might reflect a role for ring-stage adhesion and sequestration in some instances. Although case B had a higher ring parasitemia in placental blood, 97% of placental parasites were mature forms. In another study, early ring forms adhered to placental tissue and endothelial cells in vitro, but the level of adhesion at 8 h of development was only around 11% of that for mature forms (14). A separate study reported no adhesion of ring forms to cultured syncytiotrophoblasts (12). Our data suggest that the majority of ring-stage IEs circulate and only sequester when they mature to pigmented trophozoites and express specific adhesion molecules. In vitro, maximal IE adhesion (10) and expression of PfEMP1 on the IE surface (23) commences among late ring forms. This may also account for the high proportion of rings observed in three placentas. Among these placentas, the majority (>80%) of rings were mid- or late stages rather than early forms. However, we note that reliably identifying the different stages of rings in clinical samples was difficult.
Examination of brain tissue collected post mortem revealed that the parasitemia of ring-stage IEs in cerebral vessels was around 10-fold higher than in peripheral blood and constituted on average 27% of all IEs identified in cerebral vessels (20). Schizonts were underrepresented, with the ratio of trophozoites to schizonts being 7:1, whereas it would be expected to be roughly equal. We found the ratio of trophozoites to schizonts in the placenta was around 4:1 (from analysis of placental washings). Adhesion of IEs to CSA, HA, and cultured syncytiotrophoblasts is reduced among schizonts compared to pigmented trophozoites (12, 15; J. G. Beeson, unpublished data).
Mature-stage P. falciparum IEs have markedly reduced deformability compared to uninfected erythrocytes, which may contribute to their accumulation in various organs (13). If rheological changes are a principal determinant of parasite sequestration, equal numbers of trophozoites and schizonts should sequester, which was not the case. Multiple factors, such as adhesion, changes in IE rheology, and other processes, may combine to augment IE sequestration in the placenta.
It is possible that the method of washing parasitized blood from placental tissue removes a greater proportion of nonadherent or weakly adherent IEs, such as ring forms and schizonts, leading to an overestimation of the proportion of these parasite stages present in the placenta. If this were the case, the placental ring-stage parasitemia may have been lower than we calculated here, further suggesting a limited role for ring-stage adhesion in placental parasite sequestration. Previously, we compared the present technique for harvesting parasites from the placenta with a more vigorous extraction method. Few differences between the methods were seen when assessing IE adhesion in vitro (2). Although histology has the potential advantage of examining sequestered parasites in situ, we found it more difficult to readily determine developmental stages by this approach than by examination of thin smears of blood washed from placental tissue. Changes in placental malaria appear to be diffuse rather than regional (22); however, a detailed evaluation is needed. Here, we sampled parasites from several different locations of each placenta in order to calculate the parasitemia and assess the developmental forms present.
To our knowledge this is the first report in which the developmental stages of IEs present in the placenta have been quantified, and the findings have significant implications for understanding the pathogenesis and immunology of placental malaria. The preferential accumulation of mature asexual-stage IEs in the blood space of the placenta is consistent with an important role for parasite-host cell adhesion, mediated by PfEMP1, in placental infection by P. falciparum.
| ACKNOWLEDGMENTS |
|---|
Funding for this work was provided by the National Health and Medical Research Council of Australia (Travel Award for Research Training to J.G.B.), The Wellcome Trust, United Kingdom (Career Development and Senior Research Fellowships to S.J.R.), and the Royal Australasian College of Physicians (Cottrell Fellowship to J.G.B).
| FOOTNOTES |
|---|
| REFERENCES |
|---|
|
|
|---|
| 1. | Beeson, J. G., and G. V. Brown. 2002. Pathogenesis of Plasmodium falciparum malaria: the roles of parasite adhesion and antigenic variation. Cell. Mol. Life Sci. 59:258-271.[CrossRef][Medline] |
| 2. | Beeson, J. G., G. V. Brown, M. E. Molyneux, C. Mhango, F. Dzinjalamala, and S. J. Rogerson. 1999. Plasmodium falciparum isolates from infected pregnant women and children are associated with distinct adhesive and antigenic properties. J. Infect. Dis. 180:464-472.[CrossRef][Medline] |
| 3. | Beeson, J. G., J. C. Reeder, S. J. Rogerson, and G. V. Brown. 2001. Parasite adhesion and immune evasion in placental malaria. Trends Parasitol. 17:331-337.[CrossRef][Medline] |
| 4. | Beeson, J. G., S. J. Rogerson, B. M. Cooke, J. C. Reeder, W. Chai, A. M. Lawson, M. E. Molyneux, and G. V. Brown. 2000. Adhesion of Plasmodium falciparum-infected erythrocytes to hyaluronic acid in placental malaria. Nat. Med. 6:86-90.[CrossRef][Medline] |
| 5. | Brabin, B. J. 1983. An analysis of malaria in pregnancy in Africa. Bull. W. H. O. 61:1005-1016.[Medline] |
| 6. | Clark, H. C. 1915. The diagnostic value of the placental film in aestivo-autumnal malaria. J. Exp. Med. 22:427-444.[Abstract] |
| 7. | Desowitz, R., and G. Buchbinder. 1992. The absence of Plasmodium falciparum gametocytes in the placental blood of a woman with a peripheral parasitaemia. Ann. Trop. Med. Parasitol. 86:191-192.[Medline] |
| 8. | Flick, K., C. Scholander, Q. Chen, V. Fernandez, B. Pouvelle, J. Gysin, and M. Wahlgren. 2001. Role of nonimmune IgG bound to PfEMP1 in placental malaria. Science 293:2098-2100. |
| 9. | Fried, M., and P. E. Duffy. 1996. Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta. Science 272:1502-1504.[Abstract] |
| 10. | Gardner, J. P., R. A. Pinches, D. J. Roberts, and C. I. Newbold. 1996. Variant antigens and endothelial receptor adhesion in Plasmodium falciparum. Proc. Natl. Acad. Sci. USA 93:3503-3508. |
| 11. | Magowan, C., W. Wollish, L. Anderson, and J. Leech. 1988. Cytoadherence by Plasmodium falciparum-infected erythrocytes is correlated with the expression of a family of variable proteins on infected erythrocytes. J. Exp. Med. 168:1307-1320. |
| 12. | Maubert, B., L. J. Guilbert, and P. Deloron. 1997. Cytoadherence of Plasmodium falciparum to intercellular adhesion molecule 1 and chondroitin-4-sulfate expressed by the syncytiotrophoblast in the human placenta. Infect. Immun. 65:1251-1257.[Abstract] |
| 13. | Nash, G. B., E. O'Brien, E. C. Gordon-Smith, and J. A. Dormandy. 1989. Abnormalities in the mechanical properties of red blood cells caused by Plasmodium falciparum. Blood 74:855-861. |
| 14. | Pouvelle, B., P. A. Buffet, C. Lepolard, A. Scherf, and J. Gysin. 2000. Cytoadhesion of Plasmodium falciparum ring-stage-infected erythrocytes. Nat. Med. 6:1264-1268.[CrossRef][Medline] |
| 15. | Pouvelle, B., T. Fusai, C. Lepolard, and J. Gysin. 1998. Biological and biochemical characteristics of cytoadhesion of Plasmodium falciparum-infected erythrocytes to chondroitin-4-sulfate. Infect. Immun. 66:4950-4956. |
| 16. | Reeder, J. C., A. F. Cowman, K. M. Davern, J. G. Beeson, J. K. Thompson, S. J. Rogerson, and G. V. Brown. 1999. The adhesion of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate A is mediated by PfEMP1. Proc. Natl. Acad. Sci. USA 96:5198-5202. |
| 17. | Roberts, D. J., B.-A. Biggs, G. Brown, and C. I. Newbold. 1993. Protection, pathogenesis and phenotypic plasticity in Plasmodium falciparum malaria. Parasitol. Today 9:281-285. |
| 18. | Rogerson, S. J., S. C. Chaiyaroj, K. Ng, J. C. Reeder, and G. V. Brown. 1995. Chondroitin sulfate A is a cell surface receptor for Plasmodium falciparum-infected erythrocytes. J. Exp. Med. 182:15-20. |
| 19. | Rogerson, S. J., N. R. van den Broek, E. Chaluluka, C. Qonqwane, C. G. Mhango, and M. E. Molyneux. 2000. Malaria and anemia in antenatal women in Blantyre, Malawi: a twelve month survey. Am. J. Trop. Med. Hyg. 62:335-340.[Abstract] |
| 20. | Silamut, K., N. H. Phu, C. Whitty, G. D. H. Turner, K. Louwrier, N. T. H. Mai, J. A. Simpson, T. T. Hien, and N. J. White. 1999. A quantitative analysis of the microvascular sequestration of malaria parasites in the human brain. Am. J. Pathol. 155:395-410. |
| 21. | Treutiger, C. J., J. Carlson, C. Scholander, and M. Wahlgren. 1998. The time course of cytoadhesion, immunoglobulin binding, rosette formation, and serum-induced agglutination of Plasmodium falciparum-infected erythrocytes. Am. J. Trop. Med. Hyg. 59:202-207.[Abstract] |
| 22. | Walter, P. R., Y. Garin, and P. Blot. 1982. Placental pathologic changes in malaria. A histologic and ultrastructural study. Am. J. Pathol. 109:330-342.[Abstract] |
| 23. | Waterkeyn, J. F., M. E. Wickham, K. Davern, B. M. Cooke, J. C. Reeder, J. G. Culvenor, R. F. Waller, and A. F. Cowman. 2000. Targeted mutagenesis of Plasmodium falciparum erythrocyte membrane protein 3 (PfEMP3) disrupts cytoadherence of malaria-infected red blood cells. EMBO J. 19:2813-2823.[CrossRef][Medline] |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|